I do. I think it might pop on the news initialli, but then selloff on profit-taking. I have seen it happen a million times on FDA approvals. However, unlike other FDA trades, I think the profit-taking may be limited to a short timeframe here, due to the next FDA decision being right around the corner, and that one is the bigger one in my opinion, since it is basically a no expense all profit situation for ALKS. I do believe that both submissions will get approval.
I would agree if there was not a 2nd pending approval within 10 days. But if you are long or speculate, more likely, you keep the stock until the 2nd approval. If you are short, you try to cover your position after the first approval and before the second one. So, I would not see a big drop after this approval. we are 2% down now, but with low volumes. Few people avoiding risks, and obviously, new buyers are limited, because we are so close to the release.